Treatment of vasculitis.
Several clinical and pathologic types of vasculitis have been identified, but basically there are two categories: large and small vessel vasculitis; and type III immune complex and type IV delayed hypersensitivity lymphocytic vasculitis. Rapid advances in therapy of several forms of vasculitis indicate that more use should be made of active agents across the spectrum of vasculitis syndromes. This review should make this possible.
D006801:Humans; D007105:Immune Complex Diseases / Q000145:classification*; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*; D014657:Vasculitis / Q000145:classification / Q000188:drug therapy* / Q000276:immunology
D007166:Immunosuppressive Agents; D013449:Sulfonamides